A Phase I Study of Iso-Fludelone in Patients with Advanced Solid Tumors
[Protocol 10-202] |
Gounder, Mrinal |
|
A Phase 1B/II Study of GDC-0449 Plus RO4929097 in Advanced/Metastatic Sarcomas
[Protocol 10-049] |
Gounder, Mrinal |
|
A Phase II Study of Ipilimumab after Completion of Chemotherapy in Women with Recurrent Platinum-Sensitive Ovarian Cancer with Measurable Residual Disease
[Protocol 12-152] |
Grisham, Rachel |
|
A Phase IB Study of MEK162 plus Paclitaxel in Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-192] |
Grisham, Rachel |
|
Hereditary Colorectal Cancer Family Registry
[Protocol 01-110] |
Guillem, Jose |
- Colorectal Cancer
- Hereditary Cancer & Genetics
|
A Phase III Study of Celecoxib in Young People with Familial Adenomatous Polyposis
[Protocol 10-176] |
Guillem, Jose |
|
Ofatumumab with or without Bendamustine for Patients with Mantle Cell Lymphoma Who Cannot Have an Autologous Stem Cell Transplant
[Protocol 11-050] |
Hamlin, Paul |
|
A Phase II Study of Brentuximab (SGN-35) Given Before and After Adriamycin, Vinblastine, and Dacarbazine Therapy in Older Adults with Untreated Hodgkin Lymphoma
[Protocol 11-201] |
Hamlin, Paul |
|
A Phase III Study of Inotuzumab Ozogamicin with Rituximab versus Standard Therapy for Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
[Protocol 12-005] |
Hamlin, Paul |
|
A Comprehensive Assessment to Predict Side Effects from Chemotherapy and an Evaluation of Pre-Phase Chemotherapy in Older Patients with Non-Hodgkin Lymphoma
[Protocol 13-028] |
Hamlin, Paul |
|
A Phase III Study of Ibritumomab Tiuxetan versus Observation in Older Patients with Diffuse Large B-Cell Lymphoma in Remission following R-CHOP
[Protocol 12-061] |
Hamlin, Paul |
|
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
[Protocol 12-018] |
Hassoun, Hani |
|
A Pilot Study of Bortezomib/Dexamethasone Followed by Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone for the Initial Treatment of MIDD Associated with Multiple Myeloma and Amyloidosis
[Protocol 11-061] |
Hassoun, Hani |
- Hematology
- Hematologic Disorders
- Multiple Myeloma
|
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
[Protocol 11-107] |
Hassoun, Hani |
|
An Evaluation of Perceptions and Quality of Life Among Patients Receiving Ipilimumab for Melanoma
[Protocol 11-184] |
Hay, Jennifer |
|
A Phase III Study of Gemcitabine, Docetaxel, and Doxorubicin versus Observation in Women with High-Grade Uterine Leiomyosarcoma
[Protocol 12-177] |
Hensley, Martee |
- Endometrial and other Uterine Cancers
- Leiomyosarcoma
- Uterine Cancer
- Leiomyosarcoma
- Sarcomas
- Leiomyosarcoma
- Soft Tissue Sarcoma
|
A Phase III Study of Paclitaxel plus Carboplatin Versus Ifosfamide plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Persistent or Recurrent Carcinosarcoma of the Uterus
[Protocol 10-007] |
Hensley, Martee |
- Endometrial and other Uterine Cancers
- Sarcomas
|
A Phase III Study of Trabectedin or Dacarbazine for Previously Treated Advanced Liposarcoma or Leiomyosarcoma
[Protocol 11-143] |
Hensley, Martee |
- Endometrial and other Uterine Cancers
- Leiomyosarcoma
- Sarcomas
- Leiomyosarcoma
- Soft Tissue Sarcoma
|
A Phase III Study of Docetaxel and Gemcitabine With or Without Bevacizumab in Women with Recurrent or Advanced Leiomyosarcoma of the Uterus
[Protocol 10-048] |
Hensley, Martee |
- Endometrial and other Uterine Cancers
- Leiomyosarcoma
- Uterine Cancer
- Leiomyosarcoma
- Sarcomas
|
A Phase II Study of MK-2206 in Patients with Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
[Protocol 11-193] |
Ho, Alan |
|
